Ken Takizawa

1.5k total citations
60 papers, 1.1k citations indexed

About

Ken Takizawa is a scholar working on Obstetrics and Gynecology, Surgery and Reproductive Medicine. According to data from OpenAlex, Ken Takizawa has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Obstetrics and Gynecology, 22 papers in Surgery and 16 papers in Reproductive Medicine. Recurrent topics in Ken Takizawa's work include Endometrial and Cervical Cancer Treatments (24 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cervical Cancer and HPV Research (11 papers). Ken Takizawa is often cited by papers focused on Endometrial and Cervical Cancer Treatments (24 papers), Ovarian cancer diagnosis and treatment (16 papers) and Cervical Cancer and HPV Research (11 papers). Ken Takizawa collaborates with scholars based in Japan, United States and Taiwan. Ken Takizawa's co-authors include Nobuhiro Takeshima, Mitsunori Matsumae, Kenji Umayahara, Kiyoshi Fujiwara, Satoshi Yatsushiro, Kagayaki Kuroda, Yasuo Hirai, Katsuhiko Hasumi, Takatoshi Sorimachi and Akihiro Hirayama and has published in prestigious journals such as Journal of neurosurgery, British Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Ken Takizawa

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Takizawa Japan 20 518 388 356 270 203 60 1.1k
Annie Buénerd France 18 809 1.6× 450 1.2× 196 0.6× 451 1.7× 36 0.2× 48 1.3k
J. M. Lauweryns Belgium 15 456 0.9× 514 1.3× 235 0.7× 95 0.4× 50 0.2× 29 1.2k
Masato Kita Japan 16 259 0.5× 246 0.6× 79 0.2× 51 0.2× 33 0.2× 55 853
J L Stern United States 11 767 1.5× 682 1.8× 283 0.8× 193 0.7× 51 0.3× 16 1.3k
Michimasa Matsuo Japan 11 149 0.3× 180 0.5× 245 0.7× 77 0.3× 34 0.2× 30 656
R Yazigi United States 16 338 0.7× 349 0.9× 166 0.5× 133 0.5× 45 0.2× 37 704
Suguru Kakite Japan 16 107 0.2× 148 0.4× 81 0.2× 113 0.4× 25 0.1× 26 707
Donald R. Eisert United States 16 52 0.1× 34 0.1× 207 0.6× 120 0.4× 37 0.2× 24 683
Masako Ikemura Japan 18 45 0.1× 42 0.1× 133 0.4× 134 0.5× 163 0.8× 96 1.1k
Päivi Kannisto Sweden 18 347 0.7× 345 0.9× 202 0.6× 239 0.9× 154 0.8× 63 997

Countries citing papers authored by Ken Takizawa

Since Specialization
Citations

This map shows the geographic impact of Ken Takizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takizawa more than expected).

Fields of papers citing papers by Ken Takizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Takizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takizawa. The network helps show where Ken Takizawa may publish in the future.

Co-authorship network of co-authors of Ken Takizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takizawa. A scholar is included among the top collaborators of Ken Takizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takizawa. Ken Takizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goto, Shigenori, Yasuhisa Terao, Takashi Kamigaki, et al.. (2020). Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix. Anticancer Research. 40(8). 4741–4748. 5 indexed citations
2.
3.
4.
Umayahara, Kenji, Munetaka Takekuma, Yasuyuki Hirashima, et al.. (2015). Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial. Gynecologic Oncology. 140(2). 253–258. 13 indexed citations
5.
Iwase, Haruko, Toshio Takada, Hidetaka Nomura, et al.. (2014). Clinical features of long-term survivors of recurrent epithelial ovarian cancer. International Journal of Clinical Oncology. 20(1). 143–149. 14 indexed citations
6.
Fujiwara, Hiroyuki, Mitsuaki Suzuki, Nobuhiro Takeshima, et al.. (2014). Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women. Tumor Biology. 36(2). 1045–1053. 43 indexed citations
7.
Mikami, Mikio, Yoichi Aoki, Masaru Sakamoto, et al.. (2013). Current Surgical Principle for Uterine Cervical Cancer of Stages Ia2, Ib1, and IIa1 in Japan. International Journal of Gynecological Cancer. 23(9). 1655–1662. 12 indexed citations
8.
Takada, Toshio, Haruko Iwase, Hidetaka Nomura, et al.. (2012). Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary. International Journal of Gynecological Cancer. 22(4). 573–578. 29 indexed citations
9.
Omatsu, Kohei, Nobuhiro Takeshima, Maki Matoda, et al.. (2011). Unexpected tumor progression after conization for carcinoma in situ of the uterine cervix. Journal of obstetrics and gynaecology research. 38(1). 84–88. 3 indexed citations
10.
Takeshima, Nobuhiro, Tsuyoshi Ota, Kohei Omatsu, et al.. (2010). Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer—Irinotecan and platinum chemotherapy. Gynecologic Oncology. 119(2). 212–216. 34 indexed citations
11.
Ota, Tsuyoshi, et al.. (2010). Shimodaira-Taniguchi Conization Method. International Journal of Gynecological Cancer. 20(6). 1025–1030. 9 indexed citations
12.
Kokawa, Katsuji, Naohiko Umesaki, Kaichiro Yamamoto, et al.. (2009). Phase I study of irinotecan combined with mitomycin-C and 5-fluorouracil for gynecological malignancies: the JGOG study.. PubMed. 28(5B). 2933–9. 2 indexed citations
13.
Umayahara, Kenji, Nobuhiro Takeshima, Takayuki Nose, et al.. (2009). Phase I Study of Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel Chemotherapy for Locally Advanced Cervical Carcinoma in Japanese Women. International Journal of Gynecological Cancer. 19(4). 723–727. 11 indexed citations
14.
Sugiyama, Yuko, Nobuhiro Takeshima, Yasuo Hirai, et al.. (2008). Efficacy of endometrial cytology versus biopsy in endometrial cancer detection. The Journal of the Japanese Society of Clinical Cytology. 47(4). 324–329.
15.
Takeshima, Nobuhiro, Kenji Umayahara, Kiyoshi Fujiwara, et al.. (2006). Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer. Gynecologic Oncology. 102(2). 214–217. 9 indexed citations
16.
Ito, Takashi, Koichi Sato, Masahiro Yoshioka, et al.. (1998). [Continuous arterial infusion of protease inhibitor with supplementary therapy for the patients with severe acute pancreatitis--clinical effect of arterial injection of ulinastatin].. PubMed. 95(11). 1229–34. 8 indexed citations
17.
Ito, Takashi, Masahiro Yoshioka, Mikiya Tokui, et al.. (1994). [A case of severe acute pancreatitis successfully treated by continuous arterial infusion of a protease inhibitor].. PubMed. 91(10). 2021–5. 1 indexed citations
18.
Takizawa, Ken, et al.. (1993). A Case of Primary Squamous Cell Carcinoma of the Ileum.. The Japanese Journal of Gastroenterological Surgery. 26(4). 1120–1124. 2 indexed citations
19.
Takizawa, Ken, et al.. (1988). ANTIBACTERIAL AND CLINICAL EFFECTS OF A NEWLY SYNTHESIZED ANTIBOITIC, CS-807, IN GYNECOLOGICAL INFECTIONS. 36(1). 903–906. 1 indexed citations
20.
Takizawa, Ken, et al.. (1981). AN EVALUATION OF PREOPERATIVE BOWEL PREPARATION IN ELECTIVE COLORECTAL SURGERY. The Japanese Journal of Gastroenterological Surgery. 14(1). 86–90.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annie Buénerd Breakdown of academic impact, for papers by J. M. Lauweryns Breakdown of academic impact, for papers by Masato Kita Breakdown of academic impact, for papers by J L Stern Breakdown of academic impact, for papers by Michimasa Matsuo Breakdown of academic impact, for papers by R Yazigi Breakdown of academic impact, for papers by Suguru Kakite Breakdown of academic impact, for papers by Donald R. Eisert Breakdown of academic impact, for papers by Masako Ikemura Breakdown of academic impact, for papers by Päivi Kannisto
Rankless by CCL
2026